ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Madrid, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Breast Cancer
Cancer
Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Colorectal Cancer

Prostate Cancer trials near Madrid, MD, ESP:

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer (SABRE)

the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...

Active, not recruiting
Prostate Cancer
Device: SpaceOAR Vue System
Boston Scientific
Boston Scientific

Madrid, Spain and 29 other locations

primary trial objective is to demonstrate that ODM-201 produces prostate-specific antigen (PSA) response rates at 24 weeks (defined as ≥80% ...

Active, not recruiting
Prostate Cancer
Drug: ADT
Drug: ODM-201

Phase 2

European Organisation for Research and Treatment of Cancer (EORTC)

Madrid, Spain and 12 other locations

(PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer agents in participants with metastatic prostate cancer...

Enrolling
Metastatic Prostate Cancer
Drug: Palacaparib (AZD9574)
Drug: Docetaxel

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Madrid, Spain and 37 other locations

This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisi...

Enrolling
Prostatic Disease
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Drug: Gedatolisib
Drug: Darolutamide

Phase 1, Phase 2

Celcuity

Madrid, Spain and 12 other locations

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...

Enrolling
Metastatic Prostate Cancer
Drug: AZD9574
Drug: AZD0516

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Madrid, Spain and 51 other locations

pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007
Drug: Darolutamide

Phase 1

Janux Therapeutics

Madrid, Spain and 37 other locations

Metastatic prostate cancer is an incurable disease that typically spreads beyond the prostate. The standard of care is to ...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Drug: ADT (androgen deprivation therapy)
Drug: Nivolumab 10 MG/ML

Phase 2, Phase 3

Spanish Oncology Genito-Urinary Group

Madrid, Spain and 29 other locations

There are many treatment options for men with various stages of prostate cancer. Some treatments work well for a while but can caus ...

Enrolling
Hormone-refractory Prostate Cancer
Drug: VIR-5500
Drug: Androgen receptor signaling inhibitor (ARSI)

Phase 1

Astellas
Astellas

Madrid, Spain and 25 other locations

This study is being conducted to learn more about the safety, tolerability, and effectiveness of an experimental treatment for metastatic prostate...

Enrolling
Prostate Cancer
Drug: AZD6621

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Madrid, Spain and 25 other locations

and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: abiraterone acetate
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Madrid, Spain and 131 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems